These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2834502)

  • 1. [Biological criteria for the evaluation of prophylactic treatment with a low molecular weight heparin (Kabi 2165)].
    Le Querrec A; Derlon A; Deshayes JP; Lefrançois C; Sillard B; Delassus P; Viel JF; Kher A; Thomas M
    J Mal Vasc; 1987; 12 Suppl B():99-101. PubMed ID: 2834502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery].
    Grunebaum L; Fricker JP; Wiesel ML; Vergnes Y; Kapps J; Cazenave JP
    J Mal Vasc; 1987; 12 Suppl B():102-4. PubMed ID: 2834478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery.
    Koppenhagen K; Adolf J; Matthes M; Tröster E; Roder JD; Hass S; Fritsche HM; Wolf H
    Thromb Haemost; 1992 Jun; 67(6):627-30. PubMed ID: 1324534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial.
    Caen JP
    Thromb Haemost; 1988 Apr; 59(2):216-20. PubMed ID: 2838923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis.
    Onarheim H; Lund T; Heimdal A; Arnesjø B
    Acta Chir Scand; 1986 Oct; 152():593-6. PubMed ID: 3544625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation and thrombosis in patients with ovarian malignancy.
    von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
    Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and side effects of low-molecular weight heparin-dihydroergotamine in preventing thromboembolism in abdominal surgery].
    Voigt J; Hamelmann H; Hedderich J; Seifert J; Buchhammer T; Köhler A
    Zentralbl Chir; 1986; 111(21):1269-305. PubMed ID: 3544605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of thromboembolism with low-molecular weight heparin in pregnancy].
    Harenberg J; Leber G; Zimmermann R; Schmidt W
    Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):15-8. PubMed ID: 3569823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.
    Agnelli G; Bergqvist D; Cohen AT; Gallus AS; Gent M;
    Br J Surg; 2005 Oct; 92(10):1212-20. PubMed ID: 16175516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin: from the bench to the orthopedic patient.
    Turpie AG
    Orthopedics; 1997 Feb; 20 Suppl():10-3. PubMed ID: 9048401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of enoxaparine in preventing deep venous thrombosis following total hip prosthesis. Randomized multicenter prospective trial].
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weil D; Butel J
    Rev Chir Orthop Reparatrice Appar Mot; 1988; 74 Suppl 2():215-8. PubMed ID: 2852830
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications and clinical application of thrombosis prophylaxis. I].
    Mittelkötter U; Reith HB; Thiede A
    Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development of the low molecular weight heparin fraction CY 216 in the prevention of postoperative thrombosis in general surgery].
    Toulemonde F
    Therapie; 1988 May; 43(3):187-92. PubMed ID: 2844004
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the efficacy and tolerance of Kabi 2165 and standard heparin in the prevention of deep venous thrombosis in total hip prosthesis].
    Barre J; Pfister G; Potron G; Droulle C; Baudrillard JC; Barbier P; Kher A
    J Mal Vasc; 1987; 12 Suppl B():90-5. PubMed ID: 2834500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The risk of hemorrhaging in the prevention of thromboembolism in general surgery: comparison of low-dose heparin and heparin-dihydergot 2500].
    Ammann JF; Aebi B
    Chirurg; 1983 Jan; 54(1):29-32. PubMed ID: 6851723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism in obstetrics and gynecology.
    Krivak TC; Zorn KK
    Obstet Gynecol; 2007 Mar; 109(3):761-77. PubMed ID: 17329532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.